Neuropsychiatric lupus: getting beyond the barrier of the brain

Boumpas DT et al. Systemic lupus erythematosus: emerging concepts. Ann Int Med 1995; 122: 940-950.

Kent DL , Haynor DR , Longstreth WT Jr, Larson EB The clinical efficacy of magnetic resonance imaging in neuroimaging . Ann Int Med 1994; 120: 856-871.

Sibbitt WL Jr et al. Spin-spin relaxation of brain tissues in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 810-818.

Kovacs Jaj , Urowitz MB , Gladman DD , Zeman R. The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol 1995; 22: 1247-1253.

Kodama K. et al. Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. J Neurol Neurosurg Psych 1995; 58: 307-311.

Colamussi P. et al. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinicial manifestations. Eur J Nucl Med 1995; 22: 17-24.

Stoppe G. et al. Positron emission tomography in neuropsychiatric lupus erythematosus . Neurol 1990; 40: 304.

Carbotte RM , Denburg SD , Denburg JA , Nahmias C. , Garnett ES Glucose metabolism in neuropsychiatric systemic lupus erythematosus . J Neurol Neurosurg Psych 1992; 55: 1054-1059.

Belmont HM , Abramson SB , Lie JT Pathology and pathogenesis of vascular injury in systemic lupus erythematosus . Arthritis Rheuum 1996; 39(1): 9-22.

Brey RL , Gharavi AE , Lockshin MD Neurologic complication of antiphospholipid antibodies. In: Elkon KB (ed), Neurologic Aspects of Rheumatic Diseases. Rheum Dis Clin No Am 1933; 19: 833-850.

Toubi E. , Khamashta MA , Panarra A. , Hughes Grv. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 387.

Bluestein HG The central nervous system in systemic lupus erythematosus. In: Lahita RD (ed), Systemic Lupus Erythematosus , Churchill, Livingstone : New York , 1992, pp 639-655.

Bonfa E. et al. Association between lupus psychosis and antiribosomal P protein antibodies: measurement of antibody using a synthetic peptide antigen. N Engl J Med 1987; 317: 255-271.

Pereira RM , Yoshinari NH , De Oliveira RM , Cossermelli W. Antiganglioside antibodies in patients with neuropsychiatric systemic lupus erythematosus. Lupus 1992; 1: 175-179.

Hanly JG , Hong C. , White TD Brain synaptosomal antibodies in systemic lupus erythematosus. Lupus 1993; 2: 35-45.

Watanabe T. , Sato T. , Uchiumi T. , Arakawa M. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of antiribosomal P antibody. Lupus 1996; 5: 178-183.

Bonfa E. , Chu JL , Brot N. , Elkon K. Lupus antiribosomal antibodies show limited heterogeneity and are predominantly of the IgG1 and IgG2 subclasses. Clin Immunol Immunopathol 1987; 45: 129-138.

Sonoda E. et al. Differential regulation of IgA production by TGF-β induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgAsecreting cells. Cell Immunol 1992; 140: 158-172.

McIntyre TM , Kehry MR , Snapper CM Novel in vitro model for high-rate IgA class switching. J Immunol 1995; 154: 3156-3161.

Ohman S. , Emerudh J. , Roberg M. , Forsberg P. Determination of total and herpes simplex virus-specific monomeric and dimeric IgA in serum and cerobrospinal fluid by ultracentrifugation. Ann Clin Biochem 1995; 32: 550-556.

Koren E. , Reichlin MW , Kossel M. , Fugate RD , Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992; 89: 1236-1241.

Gaburo N. Jr et al. In vivo effects of antiribosomal P protein antibody injections into the lateral ventricle of the rat brain. Arthritis Rheum 1995; 38: S297.

Golombek SJ , Graus F. , Elkon KB Autoantibodies in the cerobrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum 1986; 29: 1090-1097.

Mevorach D. , Raz E. , Steiner I. Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement . Lupus 1994; 3: 117-121.

Mevorach D. et al. Intrathecal synthesis of autoantibodies in patients with neuropsychiatric lupus. Arthritis Rheum 1996; 38: S301.

Hickey WF , Hsu BL , Kimura H. T lymphocyte entry into the central nervous system. J Neurosci Res 1991; 28: 254-260.

Hirohata S. , Miyamoto T. Elevated levels of interleukin-6 in cerobrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990; 33: 644-649.

Isshi K. , Hirohata S. , Hashimoto T. , Miyashita H. Systemic lupus erythematosus presenting with diffuse low density lesions in the cerebral white matter on computed axial tomography scans: its implication in the pathogenesis of diffuse central nervous system lupus. J Rheumatol 1994; 21: 1758-1762.

Sebire G. et al. In vitro production of IL-6, IL-1β, and tumor necrosis factor-α by human embryonic microglial and neural cells. J Immunol 1993; 150: 1517-1523.

Fabry Z. et al. Production of the cytokines interleukin-1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J Neuroimmunol 1993; 47: 23-34.

Hunter CA , Abrams JS , Beaman MH , Remington JS Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T cell-independent regulation of resistance to T Gondii . Infect Immun 1993; 61: 4038-4044.

Campbell IL et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci, USA 1993; 90: 10061-10065.